Case report: Toxic delirium in a patient taking amantadine and trimethoprim-sulfamethoxazole

K. V. Speeg, Jonathan A Leighton, A. L. Maldonado

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Acute mental confusion occurred in a patient on a stable dose of amantadine after he was started on trimethoprim-sulfamethoxazole. Discontinuation of the drugs led to rapid improvement. Studies in a rat model of organic cation secretion demonstrate that both amantadine and trimethoprim, but not sulfamethoxazole, inhibit the renal secretion of the organic cation procainamide. This case may represent an amantadine-trimethoprim interaction.

Original languageEnglish (US)
Pages (from-to)410-412
Number of pages3
JournalAmerican Journal of the Medical Sciences
Volume298
Issue number6
StatePublished - 1989
Externally publishedYes

Fingerprint

Amantadine
Delirium
Poisons
Sulfamethoxazole Drug Combination Trimethoprim
Cations
Procainamide
Confusion
Trimethoprim
Kidney
Pharmaceutical Preparations

Keywords

  • amantadine
  • drug interaction
  • renal secretion
  • trimethoprim

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Case report : Toxic delirium in a patient taking amantadine and trimethoprim-sulfamethoxazole. / Speeg, K. V.; Leighton, Jonathan A; Maldonado, A. L.

In: American Journal of the Medical Sciences, Vol. 298, No. 6, 1989, p. 410-412.

Research output: Contribution to journalArticle

@article{47795a260e504388b47b32c6bd7b9344,
title = "Case report: Toxic delirium in a patient taking amantadine and trimethoprim-sulfamethoxazole",
abstract = "Acute mental confusion occurred in a patient on a stable dose of amantadine after he was started on trimethoprim-sulfamethoxazole. Discontinuation of the drugs led to rapid improvement. Studies in a rat model of organic cation secretion demonstrate that both amantadine and trimethoprim, but not sulfamethoxazole, inhibit the renal secretion of the organic cation procainamide. This case may represent an amantadine-trimethoprim interaction.",
keywords = "amantadine, drug interaction, renal secretion, trimethoprim",
author = "Speeg, {K. V.} and Leighton, {Jonathan A} and Maldonado, {A. L.}",
year = "1989",
language = "English (US)",
volume = "298",
pages = "410--412",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Case report

T2 - Toxic delirium in a patient taking amantadine and trimethoprim-sulfamethoxazole

AU - Speeg, K. V.

AU - Leighton, Jonathan A

AU - Maldonado, A. L.

PY - 1989

Y1 - 1989

N2 - Acute mental confusion occurred in a patient on a stable dose of amantadine after he was started on trimethoprim-sulfamethoxazole. Discontinuation of the drugs led to rapid improvement. Studies in a rat model of organic cation secretion demonstrate that both amantadine and trimethoprim, but not sulfamethoxazole, inhibit the renal secretion of the organic cation procainamide. This case may represent an amantadine-trimethoprim interaction.

AB - Acute mental confusion occurred in a patient on a stable dose of amantadine after he was started on trimethoprim-sulfamethoxazole. Discontinuation of the drugs led to rapid improvement. Studies in a rat model of organic cation secretion demonstrate that both amantadine and trimethoprim, but not sulfamethoxazole, inhibit the renal secretion of the organic cation procainamide. This case may represent an amantadine-trimethoprim interaction.

KW - amantadine

KW - drug interaction

KW - renal secretion

KW - trimethoprim

UR - http://www.scopus.com/inward/record.url?scp=0024846923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024846923&partnerID=8YFLogxK

M3 - Article

C2 - 2596498

AN - SCOPUS:0024846923

VL - 298

SP - 410

EP - 412

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 6

ER -